Fig. 3
From: Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer
Immunofluorescence analysis of HPV positive and negative cells treated with EZH2 inhibitors. a SCC9 and b SCC104 cells processed for immunofluorescence with DAPI, H3K27me3 and EZH2 7 days post treatment with GSK 343 (0.5 uM), EPZ5687 (5uM) or DZNeP (1uM) or DMSO (untreated) were imaged and quantified using HALO. Cell counts are shown relative to untreated cells at day 7